Back to Search Start Over

Channelopathies Are a Frequent Cause of Genetic Ataxias Associated with Cerebellar Atrophy.

Authors :
Gauquelin L
Hartley T
Tarnopolsky M
Dyment DA
Brais B
Geraghty MT
Tétreault M
Ahmed S
Rojas S
Choquet K
Majewski J
Bernier F
Innes AM
Rouleau G
Suchowersky O
Boycott KM
Yoon G
Source :
Movement disorders clinical practice [Mov Disord Clin Pract] 2020 Sep 29; Vol. 7 (8), pp. 940-949. Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).
Publication Year :
2020

Abstract

Background: Cerebellar atrophy is a nonspecific imaging finding observed in a number of neurological disorders. Genetic ataxias associated with cerebellar atrophy are a heterogeneous group of conditions, rendering the approach to diagnosis challenging.<br />Objectives: To define the spectrum of genetic ataxias associated with cerebellar atrophy in a Canadian cohort and the diagnostic yield of exome sequencing for this group of conditions.<br />Methods: A total of 92 participants from 66 families with cerebellar atrophy were recruited for this multicenter prospective cohort study. Exome sequencing was performed for all participants between 2011 and 2017 as part of 1 of 2 national research programs, Finding of Rare Genetic Disease Genes or Enhanced Care for Rare Genetic Diseases in Canada.<br />Results: A genetic diagnosis was established in 53% of families (35/66). Pathogenic variants were found in 21 known genes, providing a diagnosis for 31/35 families (89%), and in 4 novel genes, accounting for 4/35 families (11%). Of the families, 31/66 (47%) remained without a genetic diagnosis. The most common diagnoses were channelopathies, which were established in 9/35 families (26%). Additional clinical findings provided useful clues to specific diagnoses.<br />Conclusions: We report on the high frequency of channelopathies as a cause of genetic ataxias associated with cerebellar atrophy and the utility of exome sequencing for this group of conditions.<br />Competing Interests: This work was performed by the Care4Rare Canada Consortium funded by Genome Canada and the Ontario Genomics Institute (OGI‐147), the Canadian Institutes of Health Research, Ontario Research Fund, Genome Alberta, Genome British Columbia, Genome Quebec, Children's Hospital of Eastern Ontario Foundation, and The Hospital for Sick Children. The authors have no conflicts of interest to declare.<br /> (© 2020 International Parkinson and Movement Disorder Society.)

Details

Language :
English
ISSN :
2330-1619
Volume :
7
Issue :
8
Database :
MEDLINE
Journal :
Movement disorders clinical practice
Publication Type :
Academic Journal
Accession number :
33163565
Full Text :
https://doi.org/10.1002/mdc3.13086